Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies
T Karantanos, I Politikos… - Blood and lymphatic …, 2017 - Taylor & Francis
Hodgkin's lymphoma (HL) is highly curable with first-line therapy. However, a minority of
patients present with refractory disease or experience relapse after completion of frontline …
patients present with refractory disease or experience relapse after completion of frontline …
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies
T Karantanos, I Politikos… - Blood and Lymphatic …, 2017 - search.proquest.com
Hodgkin's lymphoma (HL) is highly curable with first-line therapy. However, a minority of
patients present with refractory disease or experience relapse after completion of frontline …
patients present with refractory disease or experience relapse after completion of frontline …
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies
T Karantanos, I Politikos… - Blood and Lymphatic …, 2017 - dovepress.com
Hodgkin's lymphoma (HL) is highly curable with first-line therapy. However, a minority of
patients present with refractory disease or experience relapse after completion of frontline …
patients present with refractory disease or experience relapse after completion of frontline …
[HTML][HTML] Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation …
T Karantanos, I Politikos… - Blood and lymphatic …, 2017 - europepmc.org
Hodgkin's lymphoma (HL) is highly curable with first-line therapy. However, a minority of
patients present with refractory disease or experience relapse after completion of frontline …
patients present with refractory disease or experience relapse after completion of frontline …
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies.
T Karantanos, I Politikos, VA Boussiotis - Blood and Lymphatic Cancer …, 2017 - go.gale.com
Hodgkin's lymphoma (HL) is highly curable with first-line therapy. However, a minority of
patients present with refractory disease or experience relapse after completion of frontline …
patients present with refractory disease or experience relapse after completion of frontline …
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies
T Karantanos, I Politikos… - Blood and lymphatic …, 2017 - pubmed.ncbi.nlm.nih.gov
Hodgkin's lymphoma (HL) is highly curable with first-line therapy. However, a minority of
patients present with refractory disease or experience relapse after completion of frontline …
patients present with refractory disease or experience relapse after completion of frontline …
[HTML][HTML] Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation …
T Karantanos, I Politikos… - Blood and Lymphatic …, 2017 - ncbi.nlm.nih.gov
Hodgkin's lymphoma (HL) is highly curable with first-line therapy. However, a minority of
patients present with refractory disease or experience relapse after completion of frontline …
patients present with refractory disease or experience relapse after completion of frontline …
[PDF][PDF] Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation …
T Karantanos, I Politikos, VA Boussiotis - pdfs.semanticscholar.org
Hodgkin's lymphoma (HL) is highly curable with first-line therapy. However, a minority of
patients present with refractory disease or experience relapse after completion of frontline …
patients present with refractory disease or experience relapse after completion of frontline …
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies.
T Karantanos, I Politikos… - Blood and Lymphatic …, 2017 - europepmc.org
Hodgkin's lymphoma (HL) is highly curable with first-line therapy. However, a minority of
patients present with refractory disease or experience relapse after completion of frontline …
patients present with refractory disease or experience relapse after completion of frontline …
[HTML][HTML] Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation …
T Karantanos, I Politikos… - Blood and lymphatic …, 2017 - ncbi.nlm.nih.gov
Hodgkin's lymphoma (HL) is highly curable with first-line therapy. However, a minority of
patients present with refractory disease or experience relapse after completion of frontline …
patients present with refractory disease or experience relapse after completion of frontline …